We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biochip Developed to Detect Prostate Cancer Cells

By LabMedica International staff writers
Posted on 20 Jun 2018
Print article
Image: A scanning electron micrograph (SEM) of a prostate cancer cell captured on frosted slide with silica nanowires (Photo courtesy of the American Chemical Society).
Image: A scanning electron micrograph (SEM) of a prostate cancer cell captured on frosted slide with silica nanowires (Photo courtesy of the American Chemical Society).
In men with prostate cancer, some tumor cells exit the prostate gland and circulate in the blood. Detecting these cells could enable diagnosis at an earlier stage or help doctors assess whether treatment is effective.

A new type of sensor has been developed that acts like Velcro for prostate cancer cells, sticking them to a modified frosted glass slide, like those used in medical laboratories, so that they can be identified from blood samples. The low-cost method could help doctors better diagnose and monitor the disease.

Scientists at the Chinese Academy of Sciences (Beijing, China) and their colleagues developed a simpler, more cost-effective way to monitor prostate cancer cells in the blood. The team based their device on frosted glass microscope slides. The frosted area, which is used to hold and label the slide, is a sandblasted surface with tiny depressions. They added a solution to the frosted slides that caused silica nanowires to grow on their surfaces, and then they suspended antibodies that recognized prostate cancer cells from the nanowires.

After getting captured by the antibodies, circulating tumor cells became trapped in the depressions on the slide and tangled up within the nanowires, similar to the interlocking surfaces of Velcro. The team could then visualize the cancer cells with microscopy, and found that the device had a capture efficiency on par with other approaches. When the scientists tested blood samples from prostate cancer patients, the devices detected as few as 10 tumor cells in 1 mL of blood.

The biochip showed the specificity and high capture efficiency of 85.4 ± 8.3% for prostate cancer cell line (PC-3). The micro-sized frosted slides and silica nanowires allow enhanced efficiency in capture epithelial cell adhesion molecule (EpCAM) positive cells by synergistic topographic interactions. The capture efficiency of biochip increased with the increase of silica nanowires length on frosted slide. The biochip shows that micro/nanocomposite structures improve the capture efficiency of PC-3 more than 70% compared to a plain slide.

The authors concluded that the nanobiochip has been successfully applied to identify circulating tumor cells (CTCs) from whole blood specimens of prostate cancer patients. Thus, this frosted slide-based biochip may provide a cheap and effective way of clinical monitoring of CTCs. The study was published on May 17, 2018, in the journal ACS Applied Materials & Interfaces.

Related Links:
Chinese Academy of Sciences

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.